Pacific Biosciences (PACB) President & CEO Mark Van Oene Sells 26,911 Shares

What Happened
Mark Van Oene, President & CEO of Pacific Biosciences, sold 26,911 shares on August 17, 2026, generating roughly $30,409. The transaction is reported as a sale (S) at $1.13 per share in the filing; a footnote states the weighted average sale price ranged from $1.13 to $1.15.

Key Details

• Transaction date: 2026-08-17; Form 4 filed 2026-08-18 (appears timely).
• Shares sold: 26,911; report shows $1.13 per share and total proceeds of $30,409.
• Footnote F1: Sale represents shares automatically sold to cover tax withholding obligations upon vesting of restricted stock units (RSUs).
• Footnote F2: Weighted average sale price ranged $1.13–$1.15; detailed per-price breakdown available on request to the Commission.
• Shares owned after the transaction: not provided in the excerpt supplied.

Context
This was a routine withholding sale tied to RSU vesting (not an active market-timing purchase or directional trade). Such automatic sales are common for executives to satisfy tax obligations and do not, by themselves, imply a change in insider sentiment.